Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio Key International (BKYI) Gross Margin (2016 - 2025)

Bio Key International's Gross Margin history spans 16 years, with the latest figure at 76.9% for Q3 2025.

  • For Q3 2025, Gross Margin fell 141.0% year-over-year to 76.9%; the TTM value through Sep 2025 reached 78.4%, up 1882.0%, while the annual FY2024 figure was 81.39%, 6294.0% up from the prior year.
  • Gross Margin for Q3 2025 was 76.9% at Bio Key International, up from 72.65% in the prior quarter.
  • Across five years, Gross Margin topped out at 86.26% in Q1 2024 and bottomed at 5.23% in Q4 2023.
  • The 5-year median for Gross Margin is 72.65% (2025), against an average of 61.01%.
  • The largest annual shift saw Gross Margin tumbled -5259bps in 2023 before it surged 8729bps in 2024.
  • A 5-year view of Gross Margin shows it stood at 60.21% in 2021, then dropped by -27bps to 44.02% in 2022, then tumbled by -112bps to 5.23% in 2023, then soared by 1668bps to 82.06% in 2024, then dropped by -6bps to 76.9% in 2025.
  • Per Business Quant, the three most recent readings for BKYI's Gross Margin are 76.9% (Q3 2025), 72.65% (Q2 2025), and 82.61% (Q1 2025).